These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19120292)

  • 1. IFN-alpha can both protect against and promote the development of type 1 diabetes.
    Wong FS; Wen L
    Ann N Y Acad Sci; 2008 Dec; 1150():187-9. PubMed ID: 19120292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic differentiation of poly I:C from B:9-23 peptide induced experimental autoimmune diabetes.
    Paronen J; Liu E; Moriyama H; Devendra D; Ide A; Taylor R; Yu L; Miao D; Melanitou E; Eisenbarth GS
    J Autoimmun; 2004 Jun; 22(4):307-13. PubMed ID: 15120754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity.
    Devendra D; Eisenbarth GS
    Clin Immunol; 2004 Jun; 111(3):225-33. PubMed ID: 15183143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of X- and Y-box deletions on the development of diabetes in H-2Ealpha-chain transgenic nonobese diabetic mice.
    O'Shea H; Yousaf N; Altmann D; Fehervari Z; Tonks P; Hetherington C; Harach S; Bland C; Cooke A; Lund T
    Scand J Immunol; 2006 Jan; 63(1):17-25. PubMed ID: 16398697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide.
    Mori Y; Kato T; Kodaka T; Kanagawa EM; Hori S; Kanagawa O
    Int Immunol; 2008 Sep; 20(9):1231-7. PubMed ID: 18644830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a novel model system to target insulin-reactive CD8 T cells.
    Scott GS; Fishman S; Margalit A; Siew LK; Chapman S; Wen L; Gross G; Wong FS
    Ann N Y Acad Sci; 2008 Dec; 1150():54-8. PubMed ID: 19120267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility to type 1 diabetes.
    Maier LM; Wicker LS
    Curr Opin Immunol; 2005 Dec; 17(6):601-8. PubMed ID: 16226440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 diabetes: lessons for other autoimmune diseases?
    Harrison LC; Honeyman MC; Morahan G; Wentworth JM; Elkassaby S; Colman PG; Fourlanos S
    J Autoimmun; 2008 Nov; 31(3):306-10. PubMed ID: 18558477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
    Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
    J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 is required for development of islet inflammation in the RIP-CD154 transgenic mouse model of type 1 diabetes.
    Haase C; Markholst H
    Ann N Y Acad Sci; 2007 Jun; 1107():373-9. PubMed ID: 17804565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral infections as potential triggers of type 1 diabetes.
    van der Werf N; Kroese FG; Rozing J; Hillebrands JL
    Diabetes Metab Res Rev; 2007 Mar; 23(3):169-83. PubMed ID: 17103489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly (I:C) induced immune response in lymphoid tissues involves three sequential waves of type I IFN expression.
    Démoulins T; Baron ML; Kettaf N; Abdallah A; Sharif-Askari E; Sékaly RP
    Virology; 2009 Apr; 386(2):225-36. PubMed ID: 19232663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice.
    Wong FS; Hu C; Zhang L; Du W; Alexopoulou L; Flavell RA; Wen L
    Ann N Y Acad Sci; 2008 Dec; 1150():146-8. PubMed ID: 19120284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of class III MHC to susceptibility to type 1 diabetes in the NOD mouse.
    Yamaji K; Ikegami H; Fujisawa T; Noso S; Nojima K; Babaya N; Itoi-Babaya M; Kobayashi M; Hiromine Y; Makino S; Ogihara T
    Ann N Y Acad Sci; 2006 Oct; 1079():114-7. PubMed ID: 17130540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coeliac disease and reproduction: possible in vivo models].
    Stazi AV
    Ann Ist Super Sanita; 2005; 41(4):523-31. PubMed ID: 16569922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [[Insulin-dependent diabetes mellitus as a possible sequelae of treatment of viral hepatitis with interferon-alpha] ].
    Petrovicová A
    Epidemiol Mikrobiol Imunol; 2000 Nov; 49(4):158-61. PubMed ID: 11188763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
    Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
    Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of HLA-DQ alleles in peripheral blood mononuclear cells: alleles associated with susceptibility to and protection from autoimmune type 1 diabetes.
    Britten AC; Mijovic CH; Barnett AH; Kelly MA
    Int J Immunogenet; 2009 Feb; 36(1):47-57. PubMed ID: 19207936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.
    Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T
    Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.